Ento Proteins Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.38 M
as on 11-12-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 Cr
as on 11-12-2024
- Revenue %
(FY 2022)
- Profit -57135.04%
(FY 2022)
- Ebitda -36081.32%
(FY 2022)
- Net Worth -9233.52%
(FY 2022)
- Total Assets 13942.69%
(FY 2022)
About Ento Proteins
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.38 M.
The company currently has active open charges totaling ₹3.50 Cr.
Kalandan Haris, Kalandan Arif, and Kalandan Althaf serve as directors at the Company.
- CIN/LLPIN
U15209KA2021PTC145044
- Company No.
145044
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2021
- Date of AGM
09 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Dakshina Kannada, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ento Proteins?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kalandan Haris | Director | 08-Mar-2021 | Current |
Kalandan Arif | Director | 08-Mar-2021 | Current |
Kalandan Althaf | Director | 08-Mar-2021 | Current |
Financial Performance and Corporate Structure Insights of Ento Proteins.
Ento Proteins Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 57135.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 9233.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ento Proteins?
In 2022, Ento Proteins had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Mukka Proteins LimitedActive 14 years 1 month
Kalandan Haris, Kalandan Arif and 1 more are mutual person
- Haris Marine Products Private LimitedActive 5 years 1 month
Kalandan Haris, Kalandan Arif and 1 more are mutual person
- Shipwaves Online LimitedActive 9 years 9 months
Kalandan Haris and Kalandan Althaf are mutual person
- Ocean Proteins Private LimitedActive 5 years 2 months
Kalandan Haris, Kalandan Arif and 1 more are mutual person
- Atlantic Marine Products Private LimitedActive 5 years 1 month
Kalandan Haris and Kalandan Arif are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 20 Sep 2023 | ₹3.50 Cr | Open |
How Many Employees Work at Ento Proteins?
Ento Proteins has a workforce of 4 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ento Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ento Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.